Ribavirin
"Ribavirin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses.
Descriptor ID |
D012254
|
MeSH Number(s) |
D13.570.800.790
|
Concept/Terms |
Rebetol- Rebetol
- Merck Brand of Ribavirin
- Ribavirin Merck Brand
- Pfizer Brand of Ribavirin
- Essex Brand of Ribavirin
Virazole- Virazole
- Vilona
- ICN Brand of Ribavirin
Ribasphere- Ribasphere
- Three Rivers Pharmaceuticals Brand of Ribavirin
Virazide- Virazide
- Grossman Brand of Ribavirin
- Dermatech Brand of Ribavirin
|
Below are MeSH descriptors whose meaning is more general than "Ribavirin".
Below are MeSH descriptors whose meaning is more specific than "Ribavirin".
This graph shows the total number of publications written about "Ribavirin" by people in this website by year, and whether "Ribavirin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 0 | 1 | 1 |
2007 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ribavirin" by people in Profiles.
-
Ch?vez-Bueno S, Mej?as A, Merryman RA, Ahmad N, Jafri HS, Ramilo O. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Pediatr Infect Dis J. 2007 Dec; 26(12):1089-93.
-
Ch?vez-Bueno S, Mej?as A, Welliver RC. Respiratory syncytial virus bronchiolitis : current and future strategies for treatment and prophylaxis. Treat Respir Med. 2006; 5(6):483-94.